Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.

BACKGROUND: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA)...

Full description

Bibliographic Details
Main Authors: Alastair I Matheson, Lisa E Manhart, Patricia B Pavlinac, Arianna R Means, Adam Akullian, Gillian A Levine, Julie Jacobson, Erin Shutes, Judd L Walson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4023929?pdf=render
id doaj-6bad5fb13bd640848fea48a6acc29a0b
record_format Article
spelling doaj-6bad5fb13bd640848fea48a6acc29a0b2020-11-25T00:46:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9665810.1371/journal.pone.0096658Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.Alastair I MathesonLisa E ManhartPatricia B PavlinacArianna R MeansAdam AkullianGillian A LevineJulie JacobsonErin ShutesJudd L WalsonBACKGROUND: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA) of azithromycin (AZM) prompted the development of visually compelling, easy-to-use tools that synthesize country-specific data on factors that would influence both potential AZM benefit and MDA implementation success. METHODOLOGY/PRINCIPAL FINDINGS: We assessed the opportunity to reduce mortality and the feasibility of implementing such a program, creating Opportunity and Feasibility Indices, respectively. Countries with high childhood mortality were included. A Country Ranking Index combined key variables from the previous two Indices and applied a scoring system to identify high-priority countries. We compared four scenarios with varying weights given to each variable. Twenty-five countries met inclusion criteria. We created easily visualized tools to display the results of the Opportunity and Feasibility Indices. The Opportunity Index revealed substantial variation in the opportunity for an MDA of AZM program to reduce mortality, even among countries with high overall childhood mortality. The Feasibility Index demonstrated that implementing such a program would be most challenging in the countries that could see greatest benefit. Based on the Country Ranking Index, Equatorial Guinea would benefit the most from the MZA of AZM in three of the four scenarios we tested. CONCLUSIONS/SIGNIFICANCE: These visually accessible tools can be adapted or refined to include other metrics deemed important by stakeholders, and provide a quantitative approach to prioritization for intervention implementation. The need to explicitly state metrics and their weighting encourages thoughtful and transparent decision making. The objective and data-driven approach promoted by the three Indices may foster more efficient use of resources.http://europepmc.org/articles/PMC4023929?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Alastair I Matheson
Lisa E Manhart
Patricia B Pavlinac
Arianna R Means
Adam Akullian
Gillian A Levine
Julie Jacobson
Erin Shutes
Judd L Walson
spellingShingle Alastair I Matheson
Lisa E Manhart
Patricia B Pavlinac
Arianna R Means
Adam Akullian
Gillian A Levine
Julie Jacobson
Erin Shutes
Judd L Walson
Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
PLoS ONE
author_facet Alastair I Matheson
Lisa E Manhart
Patricia B Pavlinac
Arianna R Means
Adam Akullian
Gillian A Levine
Julie Jacobson
Erin Shutes
Judd L Walson
author_sort Alastair I Matheson
title Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
title_short Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
title_full Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
title_fullStr Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
title_full_unstemmed Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
title_sort prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description BACKGROUND: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA) of azithromycin (AZM) prompted the development of visually compelling, easy-to-use tools that synthesize country-specific data on factors that would influence both potential AZM benefit and MDA implementation success. METHODOLOGY/PRINCIPAL FINDINGS: We assessed the opportunity to reduce mortality and the feasibility of implementing such a program, creating Opportunity and Feasibility Indices, respectively. Countries with high childhood mortality were included. A Country Ranking Index combined key variables from the previous two Indices and applied a scoring system to identify high-priority countries. We compared four scenarios with varying weights given to each variable. Twenty-five countries met inclusion criteria. We created easily visualized tools to display the results of the Opportunity and Feasibility Indices. The Opportunity Index revealed substantial variation in the opportunity for an MDA of AZM program to reduce mortality, even among countries with high overall childhood mortality. The Feasibility Index demonstrated that implementing such a program would be most challenging in the countries that could see greatest benefit. Based on the Country Ranking Index, Equatorial Guinea would benefit the most from the MZA of AZM in three of the four scenarios we tested. CONCLUSIONS/SIGNIFICANCE: These visually accessible tools can be adapted or refined to include other metrics deemed important by stakeholders, and provide a quantitative approach to prioritization for intervention implementation. The need to explicitly state metrics and their weighting encourages thoughtful and transparent decision making. The objective and data-driven approach promoted by the three Indices may foster more efficient use of resources.
url http://europepmc.org/articles/PMC4023929?pdf=render
work_keys_str_mv AT alastairimatheson prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT lisaemanhart prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT patriciabpavlinac prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT ariannarmeans prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT adamakullian prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT gillianalevine prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT juliejacobson prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT erinshutes prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
AT juddlwalson prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin
_version_ 1725264753318690816